SCHEMBL24915326

SCHEMBL24915326

OCc1ccn(C2CCOC2)n1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.34
MGLL Q99685 1/20 0.34
SIGMAR1 Q99720 1/20 0.34
SOST Q9BQB4 1/20 0.34
KDR P35968 5/20 0.33
LCK P06239 1/20 0.33
FYN P06241 1/20 0.33
RET P07949 1/20 0.33
PDGFRB P09619 1/20 0.33
PDGFRA P16234 1/20 0.33
FLT1 P17948 1/20 0.33
LTK P29376 1/20 0.33
MAP2K2 P36507 1/20 0.33
FLT3 P36888 1/20 0.33
CDK8 P49336 1/20 0.33
MAP2K1 Q02750 1/20 0.33
ACVR1 Q04771 1/20 0.33
BTK Q06187 1/20 0.33
TNK2 Q07912 1/20 0.33
IKBKE Q14164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29160328 0.91 SIGMAR1 (0.38) FAAHMGLLSIGMAR1PIK3CDPIK3CA
SCHEMBL24915358 0.90 SIGMAR1 (0.41) FAAHMGLLSIGMAR1ACKR3IRAK4
SCHEMBL24915584 0.86 P2RX7 (0.33) SIGMAR1PIK3CAMTORHDAC1HDAC6
SCHEMBL19945657 0.81 HDAC1 (0.36) SIGMAR1HDAC1HDAC6
SCHEMBL26140278 0.79 HTR2C (0.33) SIGMAR1SOST
SCHEMBL31389771 0.78 SIGMAR1 (0.38) FAAHMGLLSIGMAR1HDAC1HDAC6
SCHEMBL23467541 0.77 SIGMAR1 (0.37) SIGMAR1
SCHEMBL20456693 0.77 FAAH (0.33) FAAHMGLLSIGMAR1SOSTACKR3
SCHEMBL31508142 0.77 KDR (0.33) FAAHMGLLSIGMAR1SOSTKDR
SCHEMBL20456694 0.77 FAAH (0.33) FAAHMGLLSIGMAR1SOSTACKR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230145793-A1 SUBSTITUTED PYRIMIDINE OR PYRIDINE AMINE DERIVATIVE, COMPOSITION THEREOF, AND MEDICAL USE THEREOF SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2023-05-11 US disclosed
US-20230145793-A1 SUBSTITUTED PYRIMIDINE OR PYRIDINE AMINE DERIVATIVE, COMPOSITION THEREOF, AND MEDICAL USE THEREOF SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2023-05-11 US disclosed
EP-4122927-A1 SUBSTITUTED PYRIMIDINE OR PYRIDINE AMINE DERIVATIVE, COMPOSITION THEREOF, AND MEDICAL USE THEREOF Shanghai Haiyan Pharmaceutical Technology Co., Ltd. (CN) 2023-01-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230145793-A1 SUBSTITUTED PYRIMIDINE OR PYRIDINE AMINE DERIVATIVE, COMPOSITION THEREOF, AND MEDICAL USE THEREOF ADORA2A, ADORA2B, ADORA3 FAAH 1125/4885MGLL 3008/4885SIGMAR1 580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.